Accelerate your medicinal cannabis clinical development program. From project management through to clinical trial monitoring, management and patient recruitment, we’re Australia’s leading contract research organization in the medicinal cannabis sector.
Medicinal Cannabis Research needs a different approach. Intellectual property positions are different. Budgets are smaller. Timescales are shorter. Regulatory pathways are newly established and more complex. Product companies undertaking research in the Medicinal Cannabis sector need a different research partner. A partner with hands-on experience in the sector; direct access to the largest patient pool in the country; multiple treatment sites in every state; data collection platforms that are compliant, and tailored to the medicinal cannabis sector.
Applied Cannabis Research is dedicated to assisting medicinal cannabis companies with the development of their products with a single, unified vision: the faster the clinical development stage is accomplished the quicker medicinal cannabis treatments reach those who need them – the patients.
Dr John Barlow is the Principal Investigator for the CACOS Study, Australia’s largest medicinal cannabis observational trial. He has more than 10 years experience in clinical trials in a range of medical, surgical and public health fields, particularly oncology, neurology and orthopaedics. John is a former Associate Professor in the Department of Medicine at Monash University and was a Neil Hamilton Fairley Fellow of the National Health and Medical Research Council. He holds a PhD from Monash University and has published more than 200 peer reviewed papers and abstracts encompassing a range of topics including endocrinology, clinical chemistry and drug evaluation.
Dr Melissa Benson is the General Manager of Applied Cannabis Research and has significant experience in conducting clinical trials with medicinal cannabis products. Melissa has a PhD in Neuropharmacology from the University of Queensland and has completed postdoctoral fellowships focused on drug development in the fields of refractory epilepsy and cannabinoids. She has also completed postgraduate business studies in intellectual property commercialisation.
Melissa was previously Clinical team leader at the Lambert Initiative for Cannabinoid Therapeutics based at the University of Sydney, where she oversaw development, start-up, and execution of clinical trials with medicinal cannabinoids. These projects ranged from patient observational studies to randomised, placebo-controlled trials in a breadth of disease areas including psychiatry, neurological disorders and addiction, in addition to experimental studies assessing driving performance and cognition.
Dr Benson also has experience in management of clinical trials departments within general practice settings and has expertise in patient data collection, management and statistical analysis. She also has expertise related to clinical governance and human research ethics applications with a range of institutions including local health districts, private clinics and universities and has collaborated with specialist clinicians and academic researchers locally and abroad on a range of projects within the medicinal cannabis space.